共 34 条
- [2] RENAL MEDULLARY BLOOD-FLOW - EFFECT OF VASOPRESSIN (AVP) AND THE VASCULAR ANTAGONIST D(CH2)5TYR (ME)AVP - VIDEOMICROSCOPIC STUDY IN RATS [J]. RENAL PHYSIOLOGY AND BIOCHEMISTRY, 1986, 9 (1-2): : 87 - 88
- [4] PREVENTION OF HYPONATREMIA AND CEREBRAL EDEMA BY THE VASOPRESSIN ANTAGONIST D/CH2/5TYR/ET/VAVP IN RATS TREATED WITH PITRESSIN TANNATE [J]. ACTA ENDOCRINOLOGICA, 1984, 106 (01): : 56 - 60
- [5] DESENSITIZATION OF RENAL VASOPRESSIN RECEPTOR AND VASOPRESSIN STIMULATED ADENYLATE-CYCLASE FOLLOWING DDAVP ADMINISTRATION INVIVO - PARTIAL PREVENTION OF DESENSITIZATION BY A VASOPRESSIN ANTAGONIST, D(CH2)5TYR(ME)AVP [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1987, 43 : P184 - P184
- [6] EFFECT OF THE VASOPRESSIN ANTAGONIST D/CH2/5TYR/ET/VAVP ON THE ANTIDIURETIC ACTION OF EXOGENOUS AND ENDOGENOUS VASOPRESSIN [J]. ACTA ENDOCRINOLOGICA, 1984, 106 (01): : 52 - 55
- [7] HISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY OF RENAL CORTICAL NECROSIS IN RATS TREATED WITH ESTRONE + VASOPRESSIN, AND ITS PREVENTION WITH A VASOPRESSIN ANTAGONIST [J]. BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY, 1987, 68 (01): : 35 - 43
- [9] PHARMACOLOGICAL EVALUATION OF D(CH2)5TYR(ME)AVP AS AN ANTAGONIST OF VASOPRESSIN-INDUCED CONTRACTION OF THE ISOLATED RAT CAUDAL ARTERY [J]. ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1986, 284 (01): : 72 - 84